Lithuania
Northway Biotech, a Biotechnology firm established in 2004, operates as a Contract Development and Manufacturing Organization (CDMO) with facilities in Waltham, MA, and Vilnius, Lithuania. Known for their comprehensive services, they manage the biopharmaceutical value chain extensively, from gene development to drug production within microbial and mammalian expression systems.
Northway Biotech boasts a strong capability in adjusting to project dynamics with their rapid response to changes, offering flexibility and an ability to scale capabilities. Their end-to-end offerings encompass critical elements like Cell Line Development, cGMP Manufacturing of biologics and biosimilars, Quality Assurance, and Regulatory CMC Support.
The company last received a €310.00K grant from the Eurostars SME programme on 01 July 2015. Investors seeking to engage with a nimble, scientifically robust, and geographically diverse CDMO with well-established industry expertise may find Northway Biotech an attractive prospect.
